Πίσω
Πίσω

06-07-2024

58 E. Kosmidis - The clinical importance of Mammaprint and Blueprint in women with low and high risk of recurrence

58 E. Kosmidis - The clinical importance of Mammaprint and B...

59 St. Gkoura - Treatment algorithm of HER-2 positive metastatic breast cancer

59 St. Gkoura - Treatment algorithm of HER-2 positive metast...

60 E. Aravantinou-Fatorou - Developments in metastatic hormone-positive breast cancer

60 E. Aravantinou-Fatorou - Developments in metastatic hormo...

61 Ch. Christodoulou, A. Koutras - Discussion

61 Ch. Christodoulou, A. Koutras - Discussion

62 E. Frangiadakis - Prostate cancer – New therapeutic approaches and perspectives focusing on individualized patient management

62 E. Frangiadakis - Prostate cancer – New therapeutic appro...

63 K. Koutsoukos - Kidney cancer – Focusing on the optimal therapeutic algorithm of systematic treatments for the benefit of patients

63 K. Koutsoukos - Kidney cancer – Focusing on the optimal t...

64 Th. Tegos - Developments of immunotherapy in the 1st line of metastatic NSCLC

64 Th. Tegos - Developments of immunotherapy in the 1st line...

65 I. Mountzios - The long tail effect in survival – The importance of priming

65 I. Mountzios - The long tail effect in survival – The imp...

66 M. Lykka - Navigate clinical decisions in the era of DUAL-10 (HCC and CL Paradigms)

66 M. Lykka - Navigate clinical decisions in the era of DUAL...

67 E. Yu - Relugolix: a new option with benefits for the treatment of advanced hormone sensitive prostate cancer

67 E. Yu - Relugolix: a new option with benefits for the tre...

68 Joint Session – ASCO – IMBE - GSRGT - Introduction

68 Joint Session – ASCO – IMBE - GSRGT - Introduction

69 A. Necchi & P. Spiess - Re-defining rare GU cancers based on incidence / histology / genomics and available resources

69 A. Necchi & P. Spiess - Re-defining rare GU cancers based...

70 K. Oualla - Global voice of rare GU cancers research – Steps toward academic research to promote under-represented regions

70 K. Oualla - Global voice of rare GU cancers research – St...

71 S. Gupta - Global Clinical Trials for rare GU cancers – Critical unmet need

71 S. Gupta - Global Clinical Trials for rare GU cancers – C...

72 Q&A

72 Q&A